Surgenex | Pioneering the Future Today
Surgenex® is a contract manufacturing organization specializing in 361 HCT/P allografts. Surgenex® is committed to turning innovative scientific research into industry leading human cellular and tissue-based products.
About Us - Surgenex
Pioneering the future today. Surgenex®is an industry leading biotechnology firm focused on the development and commercialization of placental tissue and musculoskeletal based implants meeting stringent quality and safety standards.
Advanced Biologics Catalog - Surgenex
View Catalog. Explore our comprehensive range of high-quality biologics designed to enhance patient outcomes. Surgenex®. Home Contact Us Reimbursement Support Login Compliance …
Site terms & Conditions - Surgenex
Surgenex, its parent, subsidiaries and affiliates, own all rights to their logos and trademarks used in connection with the Site. All other logos and trademarks appearing on the Site are the property of their respective owners.
Surgenex® | SurGraft FT®
Promote Accelerated Healing with Full-Thickness Placental Allografts. SurGraft FT® is a meticulously designed, full-thickness placental allograft that retains the intermediary layer between the amnion and chorion, enhancing handling and supporting the healing cascade.
Surgenex® | Surgenex® 360 Program
Discover Surgenex® 360, our comprehensive allograft program offering end-to-end solutions for providers. Explore our range of allograft products and learn how our all-inclusive program can elevate your practice.
Surgenex® | PelloGraft®
PelloGraft® has been shown to be effective as a protective covering in the management of chronic non-healing ulcers including diabetic, pressure, and venous ulcers. Our allografts support enhanced tissue adherence along with heightened strength and effortless handling.
Surgenex® Products | SurGraft®
SurGraft® is a dehydrated amniotic membrane allograft that is shelf-stable and minimally manipulated to maximize the benefits of the amniotic membrane. SURGENEX® provides multiple sheet sizes to provide maximum flexibility for a variety of clinical applications.
Surgenex® | SurGraft TL®
Triple-Layer Allograft Innovation. SurGraft TL® represents a state-of-the-art triple-layer amnion-derived allograft meticulously designed for wound coverage, serving as a protective barrier and facilitating advanced wound care.
Quality & Regulatory - Surgenex
Get In Touch. Surgenex® is compliant with all FDA mandated current Good Tissue Practices (cGTP), accredited by the American Association of Tissue Banks, and has patented procedures to process, disinfect, clean, preserve and inspect allografts to maximize therapeutic potential.